Forskningsresultat per år
Forskningsresultat per år
Personlig profil
Forskningsintressen
Mika Kontro, MD, PhD is an associate professor and a consultant in clinical hematology at the Helsinki University Hospital Comprehensive Cancer Center. Mika Kontro earned his PhD thesis, entitled “Individualizing therapy for acute leukemia”, in 2017.
He currently works as K. Albin Johannson Cancer Research Fellow (Finnish Cancer Institute) and as a clinical group leader in FIMM. He has a strong background in running clinical trials and was selected at 2017 for European Hematology Association Clinical Research Training program (CRTH). Mika Kontro currently chairs the Finnish AML group and is a board member of the Nordic AML Group. Currently he leads a prospective multi-center AML trial VenEx utilizing ex-vivo drug sensitivity testing for individualized patient care.
Vetenskapsgrenar
- 3122 Cancersjukdomar
Internationellt och inhemskt samarbete
Publikationer och projekt inom de senaste fem åren.
-
BCL-2/BCL-XL Inhibition Induces Apoptosis and Circumvents Venetoclax Resistance in TP53-mutated Acute Myeloid Leukemia
Vänttinen, I. M., Kytölä, S. J., Dufva, O., Hellesøy, M., Gullaksen, S-E., Ruokoranta, T., Bruck, O., Siitonen, S., Ettala, P., Pyörälä, M., Rimpilainen, J., Siitonen, T., Gjertsen, B. T., Heckman, C., Kuusanmäki, H. & Kontro, M., 8 aug. 2023, I: Hemasphere.Forskningsoutput: Tidskriftsbidrag › Mötesabstrakt › Peer review
-
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
Kuusanmäki, H., Dufva, O., Vähä-Koskela, M., Leppä, A-M., Huuhtanen, J., Vänttinen, I., Nygren, P., Klievink, J., Bouhlal, J., Pölönen, P., Zhang, Q., Adnan-Awad, S., Mancebo-Pérez, C., Saad, J., Miettinen, J., Javarappa, K. K., Aakko, S., Ruokoranta, T., Eldfors, S., Heinäniemi, M., & 9 andra, 30 mars 2023, I: Blood. 141, 13, s. 1610-1625 16 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
-
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia
Kuusanmaki, H., Kytölä, S., Vänttinen, I., Ruokoranta, T., Ranta, A., Huuhtanen, J., Suvela, M., Parsons, A., Holopainen, A., Partanen, A., Kuusisto, M. E. L., Koskela, S., Räty, R., Itälä-Remes, M., Västrik, I., Dufva, O., Siitonen, S., Porkka, K., Wennerberg, K., Heckman, C. A., & 5 andra, juli 2023, I: Haematologica. 108, 7, s. 1768-1781 14 s.Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review
Öppen tillgångFil -
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML
Batcha, A. M. N., Buckup, N., Bamopoulos, S. A., Jurinovic, V., Rothenberg-Thurley, M., Gittinger, H., Ksienzyk, B., Dufour, A., Schneider, S., Kontro, M., Saad, J., Heckman, C. A., Sauerland, C., Goerlich, D., Berdel, W. E., Woermann, B. J., Krug, U., Braess, J., Mansmann, U., Hiddermann, W., & 3 andra, 28 mars 2023, I: Blood advances. 7, 6, s. 1040-1044 5 s.Forskningsoutput: Tidskriftsbidrag › Brev › Vetenskaplig
-
Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia
Olkinuora, A., Nieminen, T. T., Douglas, S., Kauppinen, A., Kontro, M., Väänänen, J., Kankainen, M., Ristimäki, A., Mäkinen, M., Lahermo, P., Heckman, C., Saarela, J., Salonen, M., Lepistö, A., Järvinen, H., Mecklin, J-P., Kilpivaara, O., Wartiovaara-Kautto, U., Porkka, K. & Peltomäki, P., 11 sep. 2023, I: Leukemia. 37, s. 2301–2305 5 s.Forskningsoutput: Tidskriftsbidrag › Brev › Vetenskaplig › Peer review
Öppen tillgångFil
Projekter
- 4 Aktiv
-
Kontro/Suomen Hematologiyhdist.apuraha
Suomen hematologiyhdistys ry (SHY)
15/02/2023 → 31/12/2026
Projekt: Stiftelser och fonder
-
Sohlbergin säätiö 2023 Mika Kontro
Päivikki ja Sakari Sohlbergin säätiö sr.
01/01/2023 → 31/12/2023
Projekt: Stiftelser och fonder
-
AMLDT: A Prototype System for AML Digital Twins
Suomen Akatemia Projektilaskutus
01/01/2023 → 31/12/2027
Projekt: Finlands Akademi:Bilaterala samarbetsavtal, gemensamma utlysningar
-